Edwards Lifesciences Corp
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- EW [1]
- Listing exchanges
- NYSE [1]
- SEC industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies [1]
- Business sectors
- medical device [2]
- Company / filing name
- Edwards Lifesciences Corp [1]
- Headquarters location
- Irvine [2]
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614 [1]
- Founded
- 1958; 1956 [2]
- Legal form
- Delaware corporation [2]
- Incorporation jurisdiction
- Delaware, United States [1]
- Official website
- www.EdwardsLifesciences.com ↗ [2]
- Fiscal year end
- December 31 (SEC record) [1]
- ISIN (reported securities)
- US28176E1082 [2]
- CIK
- 0001099800 [1]
- SIC code
- 3842 [1]
- Country in background record
- United States; Belgium [2]
Company positioning and business
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. [3]
Background text: Wikipedia contributors, Edwards Lifesciences. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
The SEC submissions record gives Edwards Lifesciences Corp a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: EW (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Form 10-K filed; reporting period ends 2025-12-31. [5]
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 3842. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
When was Edwards Lifesciences Corp founded?
Founded: 1958; 1956. The linked source provides the background record. [2]
Where is the headquarters of Edwards Lifesciences Corp?
Headquarters location: Irvine. The linked source provides the background record. [2]
Which business sectors are recorded for Edwards Lifesciences Corp?
Business sectors: medical device. The linked source provides the background record. [2]
Edwards Lifesciences Corp relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — Edwards Lifesciences Corp filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Edwards Lifesciences (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.